Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP529212.RAFvliC-TkRYsIRt7ydRVh6sf5swfwWEH11jP5gFeUScE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP529212.RAFvliC-TkRYsIRt7ydRVh6sf5swfwWEH11jP5gFeUScE130_assertion type Assertion NP529212.RAFvliC-TkRYsIRt7ydRVh6sf5swfwWEH11jP5gFeUScE130_head.
- NP529212.RAFvliC-TkRYsIRt7ydRVh6sf5swfwWEH11jP5gFeUScE130_assertion description "[MCT1 expression is associated with developing a new therapeutic approach for cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP529212.RAFvliC-TkRYsIRt7ydRVh6sf5swfwWEH11jP5gFeUScE130_provenance.
- NP529212.RAFvliC-TkRYsIRt7ydRVh6sf5swfwWEH11jP5gFeUScE130_assertion evidence source_evidence_literature NP529212.RAFvliC-TkRYsIRt7ydRVh6sf5swfwWEH11jP5gFeUScE130_provenance.
- NP529212.RAFvliC-TkRYsIRt7ydRVh6sf5swfwWEH11jP5gFeUScE130_assertion SIO_000772 24012639 NP529212.RAFvliC-TkRYsIRt7ydRVh6sf5swfwWEH11jP5gFeUScE130_provenance.
- NP529212.RAFvliC-TkRYsIRt7ydRVh6sf5swfwWEH11jP5gFeUScE130_assertion wasDerivedFrom befree-20140225 NP529212.RAFvliC-TkRYsIRt7ydRVh6sf5swfwWEH11jP5gFeUScE130_provenance.
- NP529212.RAFvliC-TkRYsIRt7ydRVh6sf5swfwWEH11jP5gFeUScE130_assertion wasGeneratedBy ECO_0000203 NP529212.RAFvliC-TkRYsIRt7ydRVh6sf5swfwWEH11jP5gFeUScE130_provenance.